Insulin Sensitizers Modulate GnRH Receptor Expression in PCOS Rats

Area of Science:

• Endocrinology
• Reproductive Biology
• Pharmacology

Background:

• Insulin sensitizers like metformin and pioglitazone are used for Polycystic Ovary Syndrome (PCOS) treatment.
• Their precise role and mechanism of action in PCOS remain unclear.

Purpose of the Study:

• To investigate the effects of metformin and pioglitazone on PCOS.
• Evaluate impact on leutinizing hormone (LH) and follicle stimulating hormone (FSH) receptor mRNA expression, hyperandrogenism, and insulin resistance in rat models.

Main Methods:

• Two PCOS rat models were used: high-fat diet-induced and letrozole-induced.
• Animals received metformin or pioglitazone treatment.
• Assessed metabolic parameters (glucose, insulin, lipids), reproductive parameters (estrus cycle, hormonal profile), ovarian morphology, and LH/FSH receptor mRNA expression.

Main Results:

• Both metformin and pioglitazone treatments improved metabolic and reproductive parameters in PCOS rats.
• Hyperinsulinemia and hyperandrogenism were ameliorated.
• LH and FSH receptor mRNA expression levels were altered by the treatments.

Conclusions:

• Metformin and pioglitazone demonstrate efficacy in improving key metabolic and reproductive dysfunctions associated with PCOS.
• The study provides insights into the molecular mechanisms by which these drugs exert their effects on hormone receptor expression.